DISSECTION P2381 - ESOC25-1554 OPTIMIZING PATIENT SELECTION FOR FIRST-LINE RITUXIMAB THERAPY IN PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM Jaroslava Paulasova Schwabova 1 , Katerina Benesova 1 , Tereza Ruzickova 1 , Silvia Kmetonyova 1 , Martin Elisak 1 , Ivana Sarbochova 1 , Hana Magerova 1 , Anna Olserova 1 , Jansky Petr 1 , Ales Tomek 1 1 1Department of Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic Background and Aims: Primary angiitis of the central nervous system (PACNS) is a rare yet serious condition, often challenging to diagnose and treat
As a 503A compounding pharmacy, ReviveRX prepares customized medications for individual patients based on a licensed providers prescription
Studies suggest that lowering NNMT levels may help counteract some of the mechanisms underlying impaired stem cell function in these disorders
At Luxura, every protocol is built around: Comprehensive lab analysis Hormone balance evaluation Body composition goals Individual lifestyle factors This ensures that any treatment is appropriate, safe, and aligned with long-term healthnot just short-term results
They are part of the valleys archaeological legacy and you will see them at lookout points like Antahuilque and Choquetico